Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1073
| Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1611 | Human ICA69 Protein (AC1611) | 100 µg | inquiry |
| ACPP-1060 | Recombinant Human ADAM17 Protein (Fc Tag) (AC1060) | 50 µg | inquiry |
| ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
| ACPP-1753 | Human SPR Protein (AC1753) | 5 µg | inquiry |
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1442 | Human TBCB Protein (AC1442) | 5 µg | inquiry |
| ACPP-1492 | Human PGLYRP1 Protein (AC1492) | 2 µg | inquiry |
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1283 | Human LGALS7 Protein, His (AC1283) | 5 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.